We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Ranked Income Stocks to Buy for September 12th
Read MoreHide Full Article
Here are four stocks with buy rank and strong income characteristics for investors to consider today, September 12th:
Bristol-Myers Squibb Company (BMY - Free Report) : This biopharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 3.38%, compared with the industry average of 2.77%. Its five-year average dividend yield is 2.67%.
The AES Corporation (AES - Free Report) : This diversified power generation and utility company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.8% over the last 60 days.
This Zacks Rank #2 (Buy) company has a dividend yield of 3.51%, compared with the industry average of 2.93%. Its five-year average dividend yield is 3.58%.
The Buckle, Inc. (BKE - Free Report) : This retailer of apparel, accessories and footwear has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.6% over the last 60 days.
This Zacks Rank #2 (Buy) company has a dividend yield of 4.75%, compared with the industry average of 0.00%. Its five-year average dividend yield is 3.95%.
Arbor Realty Trust, Inc. (ABR - Free Report) : This real estate investment trust and national direct lender has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days.
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 9.08%, compared with the industry average of 4.18%. Its five-year average dividend yield is 8.61%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Income Stocks to Buy for September 12th
Here are four stocks with buy rank and strong income characteristics for investors to consider today, September 12th:
Bristol-Myers Squibb Company (BMY - Free Report) : This biopharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.
Bristol-Myers Squibb Company Price and Consensus
Bristol-Myers Squibb Company price-consensus-chart | Bristol-Myers Squibb Company Quote
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 3.38%, compared with the industry average of 2.77%. Its five-year average dividend yield is 2.67%.
Bristol-Myers Squibb Company Dividend Yield (TTM)
Bristol-Myers Squibb Company dividend-yield-ttm | Bristol-Myers Squibb Company Quote
The AES Corporation (AES - Free Report) : This diversified power generation and utility company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.8% over the last 60 days.
The AES Corporation Price and Consensus
The AES Corporation price-consensus-chart | The AES Corporation Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 3.51%, compared with the industry average of 2.93%. Its five-year average dividend yield is 3.58%.
The AES Corporation Dividend Yield (TTM)
The AES Corporation dividend-yield-ttm | The AES Corporation Quote
The Buckle, Inc. (BKE - Free Report) : This retailer of apparel, accessories and footwear has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.6% over the last 60 days.
Buckle, Inc. (The) Price and Consensus
Buckle, Inc. (The) price-consensus-chart | Buckle, Inc. (The) Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 4.75%, compared with the industry average of 0.00%. Its five-year average dividend yield is 3.95%.
Buckle, Inc. (The) Dividend Yield (TTM)
Buckle, Inc. (The) dividend-yield-ttm | Buckle, Inc. (The) Quote
Arbor Realty Trust, Inc. (ABR - Free Report) : This real estate investment trust and national direct lender has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days.
Arbor Realty Trust Price and Consensus
Arbor Realty Trust price-consensus-chart | Arbor Realty Trust Quote
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 9.08%, compared with the industry average of 4.18%. Its five-year average dividend yield is 8.61%.
Arbor Realty Trust Dividend Yield (TTM)
Arbor Realty Trust dividend-yield-ttm | Arbor Realty Trust Quote
See the full list of top ranked stocks here.
Find more top income stocks with some of our great premium screens.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>